New database sheds light on generic hep C drugs in low-and middle-income countries and how to access them

13 Oct 2016 Bridie Taylor

To provide information on the intellectual property status of priority medicines in 101 low-and middle-income countries, the Medicines Patent Pool (MPP) recently launched a new database called MedsPaL (Medicines Patents and Licenses Database). For the first time hepatitis C medicines are now included alongside HIV and tuberculosis drugs.

The database, which is searchable, provides information on patents and licenses for generic production, making it easy to determine where generic hepatitis C medicines are available and the means by which they have been made available.

MPP is a United-Nations backed public health organisation working to increase access to HIV, hepatitis C and tuberculosis treatments. They achieve this by working with other stakeholders to license medicines and so encourage generic manufacture in low- and middle-income countries.

To learn more about MedsPaL and the MPP’s work, register for our upcoming webinar ‘An Introduction to Access to Generic Hepatitis C Medicines’. The webinar takes place at 14:00 on Tuesday 1 November and features experts from the University of Liverpool, TREAT Asia and MPP.

Register here.